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Abstract 
Magnesium (Mg) and its alloys have been extensively explored as potential biodegradable 
implant materials for orthopaedic applications (e.g. Fracture fixation). However, the rapid 
corrosion of Mg based alloys in physiological conditions has delayed their introduction for 
therapeutic applications to date. The present review focuses on corrosion, biocompatibility 
and surface modifications of biodegradable Mg alloys for orthopaedic applications. Initially, 
the corrosion behaviour of Mg alloys and the effect of alloying elements on corrosion and 
biocompatibility is discussed. Furthermore, the influence of polymeric deposit coatings, 
namely sol-gel, synthetic aliphatic polyesters and natural polymers on corrosion and 
biological performance of Mg and its alloy for orthopaedic applications are presented. It was 
found that inclusion of alloying elements such as Al, Mn, Ca, Zn and rare earth elements 
provides improved corrosion resistance to Mg alloys. It has been also observed that sol-gel 
and synthetic aliphatic polyesters based coatings exhibit improved corrosion resistance as 
compared to natural polymers, which has higher biocompatibility due to their biomimetic 
nature. It is concluded that, surface modification is a promising approach to improve the 
performance of Mg-based biomaterials for orthopaedic applications. 
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1 Introduction 
Metallic orthopaedic implants have been used for the replacement and/or regeneration of 
damaged hard tissues [1]. Metallic implants are preferred for their high mechanical strength 
and toughness which make them superior to polymer and polymer-ceramic composites [2]. 
Orthopaedic metallic implants can be broadly classified into permanent (e.g knee or hip 
prostheses) and temporary biodegradable implants (e.g. Screws, pins, etc.) [2]. Metals such as 
stainless steel, titanium and cobalt-chromium alloys have been employed as permanent 
implants [3, 4]. However, there are some problems associated with the use of permanent 
metallic implants [5-7]. The first such problem includes incompatibility of mechanical 
properties of metallic alloys and natural bone; for example, metal alloys have greater elastic 
modulus to that of bone [8, 9]. Under in vivo conditions, the mechanical mismatch between 
bone and implants leads to clinical phenomena called stress shielding [10, 11]. In stress 
shielding, the implant carries much of the bulk load and the surrounding bone tissue 
experiences a reduced load stress. This triggers the resorption of surrounding bone tissue 
[11]. To address this problem, permanent metallic alloys such as Co-Cr-Mo and Ti-6Al-4V 
have been manufactured into porous forms to reduce the modulus mismatch with natural 
bone [12]. A number of techniques are available to produce a porous metallic structure (fully 
porous metals or surface treatments) such as sintered metal powders, gas injection to metal 
melt, plasma spraying, use of foaming agents etc. [12]. However, development of porous 
metallic implants suffers from limitations such as brittleness, impurity of phases and limited 
control over the size, shape and distribution of porosity [13]. This limiting their orthopaedic 
applications. The second problem associated with permanent implants is mechanical wear 
and corrosion associated with the long term implantation in the body. This results in the 
release of toxic metal ions (chromium, nickel, cobalt etc.) in the body which can trigger the 
undesirable immune responses, thereby reducing the biocompatibility of metallic implants. 
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[14]. Such drawbacks have compelled researchers and clinicians to look at biodegradable 
implants, which once used, only remain for an appropriate time to fix the damage. 
Biodegradable metals have several advantages when used in orthopaedic fracture fixation 
(e.g. Screws, pins, etc.) [8]. The mechanical properties of Mg and its alloys such as Young’s 
modulus of elasticity (E= 41-45 GPa) and density (1.74-1.84 g/cm
3
) are known to be similar 
that of bone (E= 15-25 GPa and density= 1.8-2.1 g/cm
3
). This is lower than other 
biodegradable materials such as Iron-Manganese (Fe-Mn) and Zinc (Zn) based alloys [2]. 
Furthermore, Mg ions are common metabolites in the body with a daily consumption range of 
250-300 mg/day and are naturally stored in the bones [15]. Therefore, amongst biodegradable 
metals, the biocompatibility and the resemblance of mechanical properties of Mg and its 
alloys with bone makes it suitable for orthopaedic applications. 
Ceramics which are inorganic non-metallic materials that have been employed in hard tissue 
engineering applications, are collectively known as Bioceramics [16]. Bioceramics possess 
desirable properties for biomedical applications such as (i) thermo-chemically stable, (ii) 
good wear resistant and (iii) are easily mouldable. Additionally, they are biocompatible, non-
toxic and non-immunogenic [17, 18]. However, bioceramics like hydroxyapatite (HAP) are 
brittle and possess low tensile strength when compared to Mg based alloys [18]. Ceramics 
have been used commercially in various applications like coatings for implants, maxillofacial 
reconstruction and drug delivery devices [19-21].  
Polymeric materials have been employed for tissue engineering applications due to their 
ductility, biocompatibility and biodegradable nature. Polymers are composed of small 
repeating monomers which give the polymer its characteristic properties. The degree of cross 
linking of monomers determines the physiochemical nature of polymers [24]. In general, 
polymeric materials are broadly classified into synthetic and natural polymers.  
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Synthetic polymers such as aliphatic poly-ester (poly lactic acid, poly glycolic acid, poly co-
(lactic-co-glycolic acid)) can be synthesized in controlled conditions to regulate properties 
such as molecular weight and derivatization. These advantages of synthetic aliphatic 
polyesters enable their use in biomedical applications. Natural polymers such as collagen and 
protein based gels, hyaluronic based derivatives, polysaccharide chitosan and heparin based 
scaffolds have been successfully used in various tissue engineering applications [22]. Natural 
polymers share properties similar to materials in the body and thus may encourage 
expeditious tissue healing by directing cell adhesion and function. Both classes of polymer 
can be chemically modified to produce tuneable scaffold and biomedical implants with 
controlled degradation rates. [23]. Moreover, several reports showed that the by-products of 
biodegradable polymers are highly biocompatible [24]. These polymers can be engineered 
into various shapes and sizes, such as disk, rod, pellets, plates, films and fibres as required. 
Some applications include biodegradable sutures, bone grafting materials, pins, screw and 
load bearing orthopaedic devices [25]. Despite possessing many desirable properties, 
polymers have low mechanical strength when compared to bioceramics and metal implants, 
thereby hindering their applications in hard tissue engineering. Therefore polymers have been 
largely employed in soft tissue engineering and low-load bearing medical devices [25]. 
Comparatively, Mg and its alloys have advantages over polymers due mechanical strength 
similar to bone.  
From the above discussion, it can be observed that Mg based alloys have mechanical 
properties (density, yield strength, tensile strength, elongation to break and elastic modulus) 
similar to that of natural bone as compared to other biodegradable alloys, permanent 
implants, ceramics and polymers as showed in Table 1. Despite many advantages, the major 
limitation of Mg based alloys as biomedical materials is their high corrosion rate [26]. 
Corrosion results in the formation of H2 gas; which, if rapidly absorbed can lead to balloon 
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effect in vivo [27]. Additionally, shift in alkaline pH in the region surrounding the corroding 
surface is also a concern for biomedical applications [28]. 
There are some strategies to improve the corrosion behaviour and biocompatibility: 
a) Optimising the composition and microstructure, including grain size, crystalline 
structure phase and texture of the base metal through the development of manufacture 
process/methods. 
b) To improve the corrosion behaviour and biocompatibility of Mg based implants 
through protective polymer deposit coatings on Mg and its alloys. 
2 Corrosion behaviour of Mg and its alloys 
The usual degradation of biomedical metals is through the corrosion process. Generally, the 
corrosion process involves electrochemical reactions to produce oxides, hydroxides and H2 
gas species. In physiological conditions, the corrosion reactions of biodegradable metals 
including Mg and its alloys, involve the following anodic dissolution of metals and cathodic 
reduction reactions [8]. 
                                        ……………………….Eq-1 
          
         
                     ………… Eq-2 
                                           ….. Eq-3 
In general, immediately after contact with moisture/ body fluids, Mg is oxidised to form 
cations following an anodic reaction (Eq-1). The generated electrons are consumed for 
reduction of water corresponding to cathodic reactions (Eq-2). These reactions occur 
randomly over an entire surface, where galvanic couples form due to differences in 
electrochemical potential between the metal matrix and intermetallic phases or with organic 
molecules adsorbed on the surface that lead to the dissolution of biodegradable Mg and its 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
7 
 
alloys [29]. Furthermore, physiological conditions are highly corrosive environment to Mg 
and its alloys such as dissolved oxygen, proteins and electrolyte ions (chloride and hydroxide 
ions) [30]. In these environments, pure Mg is susceptible to corrosion due to its high 
electrochemical potential, which results into the migration of ions from the metal surface to 
the surrounding fluid. These electrochemical reactions result in the formation of hydroxide 
layer (M (OH)n) on the surface of Mg and its alloys (Eq-3). When this metal oxide covers 
over the entire surface, it acts as a passive layer or kinetic barrier which prevents the further 
migration of ions or chemical reactions across the metal surface [30]. However, this layer is 
slightly soluble and susceptible to breakdown, particularly in the presence of chloride ions, 
that subsequently lead to the pitting corrosion (Eqn-4) [31].  
           
            
 .......... Eq-4 
Additionally, the corrosion of Mg and its alloys produce H2 gas. Initially, the rapid formation 
of H2 gas bubble subcutaneously occurs due to the enriched chloride environment, which can 
disappear after the initial weeks following surgery [27]. Song et al., postulated that hydrogen 
release rate of 0.01 ml.cm
-2
.day
-1
 can be tolerated by the body and does not pose a serious 
threat [32]. The corrosion in body fluids is influenced by various factors such as pH, 
concentration and types of ions, protein adsorption on orthopaedic implant and influence of 
the biochemical activities of surrounding tissues [33-35]. The details of corrosion rates of Mg 
and its alloys under in vitro and in vivo conditions are given in Table 2. Typical forms of Mg 
corrosion encountered in physiological conditions are discussed in below sections:  
2.1 Galvanic corrosion 
Galvanic corrosion takes place when two dissimilar metals with different electrochemical 
potential come in contact with each other in the presence of an electrolyte [1]. The less noble 
metal acts as anode which corrodes rapidly producing by-products around the contact site 
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[36]. Galvanic corrosion of Mg is the primary issue for orthopaedic applications. In the 
galvanic series, Mg is the most active metal, and always an active anode, if it made contact 
with other metals acting as higher potential (cathode) [36, 37]. Consequently, Mg alloy 
implant is preferentially corroded. The even galvanic attack can also result from the presence 
of impurities or intermetallic elements in the Mg matrix. 
2.2 Intergranular corrosion 
Intergranular corrosion (IGC) occurs at the grain boundaries due to the precipitation of 
secondary phases [37]. For conventional metals alloys, a secondary phase is more active than 
the interior of grain, thereby causing corrosion [28]. For example, some Aluminium (Al) and 
stainless steel alloys are susceptible to IGC [28]. However, it is argued that Mg alloys suffer 
this corrosion or not [37]. Song et al, explained that this type of intergranular corrosion does 
not occur in some Mg alloys [38]. This arises as the intergranular phase distributed along the 
grain boundary is more corrosion resistant than the Mg alloy matrix. Sometime, it has been 
observed that matrix adjacent to grain boundaries corroded severely for some Mg alloy with 
Zr as a grain refiner [28]. But, this is not real interganullar corrosion, as intergranular 
(secondary) phases are still intact. Ghali et al., demonstrated the IGC attack in AE81 alloy 
[39]. When the grain boundaries with low Al concentration corrode at a faster rate than that 
in Al rich regions, as can also be seen in other Mg-Al alloys. Another study showed the AZ80 
Mg alloy IGC in 3.5% NaCl for 1 hr [37]. Where aging resulted in the decrease concentration 
of Al in α-matrix in AZ80 which forms a poor protective oxide film on the surface and 
leading to breakdown [38]. As a result, the attack at α-matrix commenced next to β-phase in 
aged AZ80. Therefore, it could be observed that concentration of Al along the grain 
boundaries affects the IGC of Mg alloys. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
9 
 
2.3 Pitting corrosion 
Pitting is a form of localized corrosion and associated with the breakdown of passivation 
layer in aggressive environment [36]. It is a serious form of corrosion when compared to 
other corrosion, since the surface pits are difficult to observe due to the presence of corrosion 
product [39]. The pits are highly corrosive, small and perforate the metal matrix. In general, 
after initial nucleation on the surface, impurities in the Mg alloy microstructure assist in 
further corrosion due to the galvanic differences in materials [40]. Moreover, the combination 
of chloride environment of body fluids and Mg ions from anodic dissolution species further 
accelerate the growth of the pit [40]. Once the pitting initiates, Mg component can be 
corroded in very short period of time, which in the case of orthopaedic applications would 
reduce the load bearing capacity of implants. Additionally, pitting increases the localised 
stress, which has the potential to form cracks [1]. The development of stress corrosion 
cracking (SCC) and metal fatigue cracks in the pits can lead to the implant failure under 
normal loading conditions. 
3 Factors affecting the corrosion resistance of Mg and its alloy 
3.1 Buffer systems and Inorganic Ions 
In the physiological conditions, several buffers are involved to maintain the pH at neutral 
condition. The commonly used corrosion prototype medium is simulated body fluid (SBF) 
which consists of buffers such as HEPES, Tris–HCl and HCO3
-
/CO2, which significantly 
affects the corrosion of Mg and its alloys [35]. The HEPES and Tris-HCl regulate the change 
in the pH by consuming the OH
-
 ions, and affect the formation of corrosion product, 
consequently accelerate the dissolution of Mg, as shown in Eqn-3. The HCO3
-
/CO2 imparts 
buffering system in the human body which not only utilise OH
- 
ions, but also induce the 
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precipitation of MgCO3 which contributes the protection against corrosion by developing the 
passivation layer on Mg [36].  
Furthermore, the presence of inorganic ions in the body fluids influences the degradation of 
Mg and its alloys primarily by two manners: (a) the abundance of Cl
-
 ions in physiological 
conditions, is aggressive in the removal of passivation layer from the surface and leading to 
pitting corrosion and (b) the presence of     
       
  ,     
     
   anions and Ca
2+
 ions 
form calcium phosphate and carbonate salt precipitate which protect the erosion of 
passivation layer on Mg and its alloys, thereby preventing the emergence of pitting corrosion 
[46].  
3.2 Mechanical stress 
The attractive high strength of biodegradable Mg alloys as compared to biodegradable 
polymers, which makes them promising for load bearing orthopaedic applications. Potential 
biodegradable biomedical devices would be exposed to the complex stress environment in 
vivo, depending upon the implantation site, and would be expected to function under various 
mechanical stresses, including fluid shear stress, compression etc.  
Gu et al., showed the increase in corrosion rate of as-extruded WE43 alloy and as-cast 
AZ91D under compression and cyclic loads [41]. The corrosion of these two alloys increased 
more than 10 times under applied loads when compared to unstressed equivalents [42]. 
Furthermore, the flow of electrolytes also influenced the corrosion rate of Mg based 
biomaterials. In case of Mg based biomaterials, the flow may produce fluid shear stress, 
which could help the deposition of corrosion product layer or, on the other hand, remove the 
locally generated OH
-
 ions, thus affecting the corrosion behaviour [42, 43]. For instance, 
Leversque et al., reported that relatively low shear stress (0.88 and 4.4 Pa) slow down the 
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corrosion rate of AM60B alloy in the static Hanks’ solution, whereas higher shear stress (8.8 
Pa) enhance the rate [151]. 
Furthermore, time dependent changes in the integrity of the mechanical properties of metal 
under prolonged mechanical stress is also a crucial factor [44]. Adequate mechanical strength 
of metal implant is required to assist the healing and is important for post-operative recovery. 
As the degradation of biomaterial proceeds; the degeneration of mechanical integrity is 
expected. The mechanical loads can accelerate this process because of both corrosion and 
stress that lead to stress corrosion cracking (SCC) and corrosion fatigue, thereby causing 
implant failure [45]. The cyclic stress develops the formation of microscopic cracks on the 
surface and also damages the protective passive layer, while the chloride environment in 
body fluids further significantly increases crack growth rate [46]. When the loading stress 
exceeds the threshold of SCC, the crack grows to a critical size, resulting in the fracture of 
the metallic implant. This infers that the environment can significantly reduce the fatigue 
limit of Mg alloys over an implantation period, producing considerable shorter failure times 
of implants.  
4  Effects of alloying element on mechanical and corrosion properties  
The Mg based biodegradable substrates can be divided into four major groups: (a) pure Mg, 
(b) Al containing alloys (AZ91, AZ31, LAE422, AM60 etc.) (c) Rare earth elements (AE21, 
WE43 etc.), and (d) Al free alloys (WE43, MgCa 0.8, MgZn6 etc.). These alloying elements 
improves the mechanical and physical properties of Mg alloys for orthopaedic applications 
by: (a) optimising grain size, (b) improve corrosion resistance, (c) providing mechanical 
strength by the formation of intermetallic states and (d) eases the manufacture process of Mg 
alloys [1]. The composition of some Mg based alloys are given in Table 3. In this section, the 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
12 
 
effects of some important alloying elements on the mechanical properties and corrosion 
behaviours of Mg alloys are also discussed.  
As an alloying element, Al is commonly used for modifying the mechanical and corrosion 
properties of Mg alloys [47]. Addition of Al (1-5%) lead to the reduction of grain size, while 
content greater than 5% does not affect the grain size [48]. Generally, Al dissolves partly in 
Mg solid solutions and precipitate as Mg17Al12 secondary phases along the grain boundaries 
[47]. The as-cast Mg-Al alloys show α- Mg matrix and β-phases mainly consisting of 
Mg17Al12 phases [49]. In the presence of electrolytes, these phases show different electrode 
potentials. The Mg17Al12 phase exhibits a passive behaviour, acting as a cathode with respect 
to the α-phase of Mg matrix, thereby accelerating the corrosion of the alloy [49]. However, 
the inert nature of Mg17Al12 phase can itself act as a corrosion barrier, thereby reducing the 
corrosion in AZ91D alloys [50]. Song et al., suggested that if β-phase volume fraction is 
higher and distributed along the grain boundary, it might act as a corrosion barrier 
surrounding the α-Mg matrix thereby reducing the corrosion rates [51]. 
Calcium (Ca) acts as a grain refining agent in Mg alloys, stabilising the grain size at levels up 
to 0.5% Ca content and decreases slightly with further addition [52]. Li et al, studied the Mg-
Ca binary alloys with increasing concentration of Ca from 0.5% to 20% [52]. The increase in 
Ca addition resulted in a high content of Mg2Ca secondary phase distribution towards grain 
boundaries. The Mg2Ca secondary phase is brittle reducing the ductility of Mg-Ca alloys with 
increase in Ca concentration. This also influences the corrosion properties of Mg alloys. A 
high volume fraction of the Mg2Ca secondary phase reduces the corrosion resistance of Mg-
Ca alloys due to the formation of micro-galvanic cells [53]. Therefore, it can be observed that 
the excessive Ca concentration accelerates the corrosion of Mg-Ca alloys, and the optimum 
Ca concentration should be ≤1% [52].  
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Manganese (Mn) is commonly used as a secondary element in Mg alloys. It has been claimed 
that the grain size decreases with increasing Mn content in Mg-Al-Mn alloy, but at levels 
above 0.4% this effect ceases [49, 15]. It has also been reported that Mn addition can improve 
the tensile strength and fatigue life of extruded AZ31, AZ61 and AZ21 alloys [49]. Song et 
al, suggested that Mn improve the corrosion resistance in Al containing Mg alloys by 
transforming the Iron (Fe) and other impurities into harmless intermetallic compounds [51]. 
However, the excessive addition of Mn reduces the corrosion resistance of Mg-Al alloys due 
to the formation of a large amount of Mn-containing Mg-Al intermetallic phases which can 
be prone to galvanic effects.  
 Similarly to Mn, Zinc (Zn) has the ability to transform impurities such as Iron (Fe), Copper 
(Cu) and Nickel (Ni) into harmless intermetallic compounds, thereby reducing their corrosion 
enhancement effect [51]. It has been reported that the addition of Zn is associated with the 
grain refinement and formation of secondary phases, thus influencing the mechanical and 
corrosion properties of Mg alloys [49, 55]. Yin et al. showed that the addition of 3% Zn in 
Mg-Zn-Mn alloys forms Mg-Zn secondary phases which precipitate out of the Mg-matrix, 
thus improving the strength through a dispersion strengthening mechanism [54]. Song et al. 
also studied the effect of Zn alloying on corrosion behaviour of Mg alloys [55]. It was found 
that micro-galvanic effects dominate the corrosion behaviour of Mg-Zn alloys, thereby 
restricting Zn to levels less than 5%. Above 5% addition results in the formation of high 
volume fraction of Mg-Zn secondary phases which act as cathodes, accelerating the corrosion 
of α- Mg matrix around the Mg–Zn phases in Mg alloys.  
Lithium (Li) can alter the lattice structure from hexagonal close-packed (h.c.p.) to body-
centred-cubic (b.c.c.) crystal structure in Mg alloys [56]. Therefore, it can be employed to 
enhance the ductility and formability of Mg alloys [49]. Li is more reactive than Mg and has 
a pronounced effect on the corrosion behaviour of Mg alloys. Li content below 9% in pure 
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Mg is beneficent to corrosion resistance, whereas excess addition of Li is detrimental to the 
corrosion resistance [57, 58].  
Rare-earth elements (REEs) are a group of seventeen elements, including fifteen lanthanides, 
scandium (Sc) and yttrium (Y). They are normally added to Mg alloys as master alloys or 
hardeners and can improve the strength and corrosion resistance by both solid solution and 
precipitation hardening [56]. The REEs can be classified into two groups (i) High solubility 
group (yttrium (Y), gadolinium (Gd), terbium (Tb), dysprosium (Dy), holmium (Ho), erbium 
(Er), thulium (Tm), ytterbium (Yb), and lutetium(Lu)) and (ii) limited solubility group 
(neodymium (Nd), lanthanum (La), cerium (Ce), praseodymium (Pr), samarium (Sm), 
europium (Eu)) [56]. For example, Y has a high solid-solution solubility in Mg and is often 
introduced along with other rare earth elements to improve creep and corrosion resistance 
[33].Moreover, most of REEs form intermetallic phases with Mg and Al which have a 
pronounced effect on the strength and corrosion of Mg alloys [59]. Several REE-doped Mg 
alloys such as WE43, Mg-5Gd, LAE442 and Mg-4Y have been investigated [33]. In WE43, 
main precipitated phases are Mg12YNd and Mg14YNd [60]. For Mg-Gd alloy, Mg5Gd 
intermetallic phases can precipitate both in grains and at grain boundaries. In Mg-Al-REE 
systems, the REE tend to form intermetallic phases with Al as Al12REE and Al11REE3 
improving strength and corrosion resistance [60]. Furthermore, the REE elements with 
limited solubility tend to form inter-metallic phases early during the solidification process 
[56]; for example, Ce aggregate at solid-liquid interfaces during solidification in Mg-Al-Ce 
alloys. During solidification, Al-Ce secondary phases form and segregate along the grain 
boundaries, effectively blocking the sliding of boundaries during deformation [49]. Al-Ce 
particles also influence the corrosion rate in Mg-Al-Ce alloys. Higher content of Ce in alloys 
leads to Al11Ce3 particles forming a network surrounding the Mg matrix acting as a micro-
galvanic cathode and thus delaying the corrosion of the Mg alloys due to a very small 
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potential difference [61]. Additionally, Al-Ce phase exhibits passivation in a wide range of 
pH, which further retards the corrosion of Mg alloys [49]. 
The characteristic impurities in Mg alloys are copper (Cu), nickel (Ni), iron (Fe) and 
beryllium (Be). Typically, Cu is limited to 100-300 ppm, Ni should not exceed 20-50 ppm 
and Fe and Be are limited to 35-50 ppm and 5 ppm respectively [56]. These impurities should 
be strictly controlled under toxic limits for biomedical applications. 
5 Pathophysiology and toxicology of alloying elements used for biodegradable Mg 
based orthopaedic implants 
The released metallic ions resulting from the corrosion of biodegradable Mg alloys may 
induce systemic toxicity to human, as well as localised toxicity to the peri-implant cells. 
Table 4 summarises the pathophysiology and toxicology of Mg and the common alloying 
elements. Generally, toxic element ions released in the body could be tolerated at very low 
concentration below its threshold level, while the excess release in the body will have adverse 
effects [62]. As Mg is the most abundant element present in the body, it shows very low 
toxicity, however in-depth biological studies are still required. Therefore, the amount of 
alloying element utilised for the manufacture of Mg based biomedical implants need to be 
optimised with respect to corrosion rates and the physiological environment at implant sites. 
It is essential that biomedical implants should be designed to control the localised release of 
metal ions below threshold levels, since the concentration of released metal ions into tissues 
influenced by various factors like (a) interfacial space between the metal and implants, (b) 
fluid flow shear stresses between the biomedical implant and bone, (c) variation in pH and (d) 
local blood supply [63]. 
The biological effects of released metal ions from biodegradable medical implants affect the 
cells of the surrounding tissue. Table 4 summarises the toxic dose at 50% cell viability 
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(TD50) of bone related cells (MC3T3E1 and MG63 cell lines). From Table 4, the alloying 
elements are divided into mild, moderate and sever toxic elements [64]. The mild toxic 
elements include Mg, Ca, Li, Al and Zr. However, some reports showed that mild toxic 
element like Al (500 nM) at very low concentration induces bone related cells proliferation 
[65]. Moderate toxic element includes Y, whereas Zn, Ni, Cu and Mn are severe toxic 
elements. Thus, moderate toxic or mild toxic elements should only be used to significantly 
improve the corrosion resistance to make the clinically feasible Mg based alloy orthopaedic 
implants [64, 65]. Additionally, other strategies such as polymer deposit coatings on Mg 
based substrates have also been employed to prevent its rapid degradation, thereby 
facilitating the controlled exposure of these metal ions into the body.  
6 Effect of polymeric deposit coatings on Mg alloys degradation and biocompatibility  
In general, the healing process of bone consists of three phases; inflammatory, reparative and 
remodelling. In inflammatory phase, the immune system of the body responds against the 
foreign body, i.e. metallic implant fixed in the body [66]. In reparative phase, integration of 
the implant with new bone and regeneration of tissue takes place. Remodelling phase is one 
of the longest phases in the healing process. For regeneration of bone, this process takes a 
minimum 12 weeks, and unfortunately most of the Mg based orthopaedic implant can 
degrade within this period [8]. Therefore, there is a need to increase corrosion resistance of 
Mg based alloys. 
A potential method for enhancing the corrosion resistance of Mg alloy without altering the 
bulk properties of material is through protective polymeric deposit coatings. Typically, the 
bulk properties of Mg regulate the mechanical integrity, but the surface properties play 
important roles in various physio-chemical processes like interaction of body fluids, adhesion 
of biomolecules and cells with biomedical implants, which initiate the corrosion process [8]. 
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Therefore, the coating should be biocompatible, but also degrade at a slower rate than that of 
Mg and its alloys. Polymeric deposit coatings are attractive, since they possess good 
biocompatibility with the body and have a range of degradation rates. This section discusses 
the role of deposit coatings (sol-gel, synthetic aliphatic-polyesters and natural polymers) in 
improving the corrosion resistance and biocompatibility of Mg alloys. 
6.1 Sol-gel coatings 
The sol-gel process involves the creation of an oxide network through progressive reactions 
of the precursor solution in a liquid medium. Basically, there are two methods of sol-gel 
preparation (a) inorganic and (b) organic [67]. The inorganic method involves evolution of 
network formation through the gelation of suspended colloidal particles of size 1-1000 nm in 
continuous liquid phase [68]. The organic method generally involves the solution of 
monomeric metal or metalloid alkaloid precursor in alcohol or organic solvent [69]. In 
general, sol-gel formation occurs in four stages (a) hydrolysis, (b) condensation and 
polymerisation of monomers to form chains and particles, (c) particle growth and (d) 
agglomeration of the polymer structures followed by the network formation throughout in 
liquid medium which increases the viscosity to form a gel [70]. In fact, hydrolysis and 
condensation reaction starts simultaneously, once the hydrolysis reaction has been initiated 
[67]. These reactions yield by-product such as water and alcohol. These processes are 
influenced by initial reaction conditions such as, pH, molar ratio of water to precursor 
solution, temperature and solvent composition [71].  
According to available literature, silane based sol-gel coatings have been used widely as an 
anti-corrosive and biocompatible coatings on Mg alloy for orthopaedic applications. There 
are several reasons using silane as anti-corrosive coatings such as (a) hydrophobic Si-O-Si 
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network (b) lower susceptibility to galvanic reactions with Mg, (c) greater adhesive 
properties, (d) easily chemically modifiable and (e) less cytotoxic in nature [72]. 
Gaur et al., reported the in vitro investigation of biodegradable composite silane coatings of 
diethylphosphatoethyltriethoxysilane (DEPETES) and bis-[3-(triethoxysilyl)propyl] 
tetrasulfide (BTESPT) for corrosion resistance of Mg-6Zn-Ca alloy in the simulated body 
fluid (SBF) [73]. Initially, the Mg alloy was pre-treated in alkaline conditions to generate a 
passivation layer, followed by coating with different volume ratios of DEPETES: BTESPT 
(1:1 to 1:4) and curing at 120 ºC for 1 hr. The corrosion resistance was evaluated by EIS 
(Electrochemical Impedance Spectroscopy) and polarisation studies. Samples coated with 
DEPETES: BTESPT (1:4) showed a near six fold increase in corrosion resistance as 
compared to bare Mg alloy in SBF. The corrosion protection of composite coating was 
attributed to highly dense Si-O-Si network formation. Similarly, Khramov et al., 
demonstrated the corrosion resistant sol-gel coatings with hybrid inorganic-organic 
phosphonate silane on AZ31B Mg alloy [74]. These coatings were prepared by mixing of 
diethylphosphonato-ethyl-triethoxy-silane (PHS) and tetraethoxy-silane (TEOS) with various 
molar ratios (PHS: TEOS- 1:1 to 1:4), and evaluated for corrosion resistance in Harrison 
solution by using EIS and potentiodynamic polarisation studies. The sample coated with 
PHS: TEOS 1:4 showed greater corrosion resistance as compared to bare and TEOS coated 
AZ31B Mg alloy respectively. This enhancement in corrosion was attributed to the chemical 
reaction of phosphonate functionalities with the surface of the alloy, resulting in improved 
hydrolytically stable P-O-Mg bonds.  
In addition to silane coatings, other metal based precursors sol-gel coatings have been used as 
a surface modification for preventing corrosion of Mg alloys. For example, Shi et al., showed 
that the titania coating on pure Mg implant was compatible with PEO (Plasma Electrolytic 
Oxidation) treated surface covers all the surface area (including pores) [75]. Furthermore, 
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Lalk et al., developed biodegradable Mg sponges coated with bioactive glass using the sol-
gel method [76]. This coating was predominantly composed of calcium phosphate and silica 
containing phosphate. The corrosion resistance was determined by soaking in DMEM 
medium (Dulbecco’s Modified Eagle’s Medium), and found to be stable for 3 days. However, 
enhanced corrosion resistance was not observed for a longer duration due to the development 
of defects in the coating. Additionally, osteoblast cells (MC3T3E1) showed good 
biocompatibility as compared to uncoated surface. Furthermore, Ishizaki et al., developed a 
corrosion resistant super hydrophobic surface on Mg alloys with cerium oxide film and 
fluroalkylsilane molecules (Figure 1) [77]. It was demonstrated that the super hydrophobic 
coating (advancing and receding contact angles are 153.2º and 146.6º respectively) enhanced 
the corrosion resistance with more than one fold as compared to bare Mg alloy in 5 % w/v 
NaCl. 
 
6.2 Synthetic aliphatic polyester coatings 
In general, biocompatible polymeric implants for orthopaedic applications have not been 
found suitable due to poor mechanical properties [1, 78]. Therefore, such polymers are 
generally deposited as anticorrosive coatings on orthopaedic implant. Usually, these 
polymeric materials enhance the corrosion resistance of Mg based metals by isolating the 
device from the fluidic and corrosive environment of the body [1, 24]. The biocompatible 
properties of polymers are critical because their presence at the interface of implant and body 
environment which could elicit the immunological response. Therefore, selecting the 
appropriate polymer coating is crucial in improving the corrosion resistance and 
biocompatibility of orthopaedic metals, including Mg and its alloys. 
There are several advantages of polymers as they can be easily modified chemically, 
physically and mechanically, enabling their use in a wide range of biomedical applications 
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[82-84]. Polymers applied as coatings on Mg based biomaterials for orthopaedic applications 
showed in Table 5, which enlist the degraded products and corrosion behaviour of polymer 
coatings. 
Synthetic aliphatic polyesters such as poly lactic acid (PLA), poly-co-lactic-glycolic acid 
(PLGA), polycaprolactone (PCL), polyethyleneimine (PEI) and many other polymers have 
been used in various biomedical applications [79]. These polymeric materials are attractive 
coatings on Mg and its alloys to control the initial rate of degradation, as their degradation 
rate is based on their molecular weight [79]. In particular, lactic and glycolic acid based 
polymers such as PLA and PGA, have been studied extensively as corrosion resistant 
coatings for orthopaedic applications. Similarly, a significant work has been carried out in co-
polymers of lactide and glycolide i.e PLGA [80]. A co-polymer of 50% lactide and glycolide 
degrades faster as compared to corresponding homo-polymer. PCL also degrades slower than 
PLA [81]. The polymeric deposit coatings on orthopaedic Mg devices can also enhance the 
mechanical strength, with nontoxic degradation products enabling osteoinductive and 
osteogenic environments [82-84]. However, many of the currently available polymers does 
not fulfil the requirement, and would require chemical modifications, if they are to be applied 
for such applications. This section discusses the corrosion resistance and biocompatibility of 
selected aliphatic polyester based polymers coating on Mg and its alloys. 
6.2.1 Poly lactic acid 
Biodegradable polymers such as poly lactic acid (PLA) have been explored extensively for 
biomedical application. PLA is highly biocompatible, semi crystalline and hydrophobic in 
nature [24]. It undergoes hydrolytic degradation and the by-products such as lactic acid is 
easily metabolised in the body without exhibiting any toxicity. However, the major drawback 
of the PLA as a load bearing implant for orthopaedic applications is that it possesses poor 
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mechanical properties as compared to bone [1]. On the other hand, it can be used as an anti-
corrosion coating on Mg alloys to slow down the hydrolytic degradation rate and the 
evolution of H2 gas [85]. However, it is depended on the concentration of PLA and the 
application technique [86]. 
Chen et al., studied the corrosion resistance properties of PLA coated on pure Mg in SBF. 
They reported bulging in the coating due to underlying accumulation of H2 gas, leading to the 
rapid destruction of Mg substrate [87]. This effect was attributed to SBF penetration through 
defects in the coating which initiated corrosion. Interestingly, Alabbasi et al, proposed the 
inappropriate use of pure Mg as a substrate for dip coating with PLA [88]. They explained 
that pure Mg is highly vulnerable to corrosion in SBF; and as consequence corrosion begins 
rapidly upon permeation of SBF through defects in the coating. Secondly, the dip coating 
resulted in non-uniform thick PLA coating with poor adhesion, thereby showing poor 
corrosion resistance. In order to show the utility of PLA in enhancing the corrosion 
resistance, Alabbasi et al., employed the spin coating technique for uniform coating of PLA 
on AZ91D Mg alloy. It has been shown that the corrosion resistance increases with 
concentration and uniformity in thickness of PLA coating on AZ91D Mg alloy. Therefore, it 
could be observed that selection appropriate coating techniques (dip coating, spin coating and 
spray coating) play an important role in studying the efficiency of polymer coating in 
preventing the corrosion of Mg and its alloys.  
Zeng et al., reported the coating of PLA on MAO (micro-arc oxidation) treated Mg-1.21Li-
1.12Ca-1.0Y alloy [86]. The corrosion resistance was evaluated by EIS and polarisation 
studies. It was observed that the MAO/PLA composite imparts corrosion resistance to the 
alloy within the physiological pH range of 7.5- 7.8. The results indicated that PLA/MAO 
composite coating can become a promising biomedical coating. Similarly Shi et al., 
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demonstrated the utility of PLA for improving the corrosion resistance of MAO treated AZ31 
Mg alloy in SBF [85]. Here, layer by layer PLA coating was prepared in PLA-chloroform 
solution. The corrosion resistance of PLA coated MAO/AZ31 alloy was compared with 
MAO/AZ31 and both PLA and AZ31 alloy in SBF for 24 hrs. The PLA/MAO alloy was 100 
and 38 times more corrosion resistant than untreated bare AZ31 and MAO treated equivalents 
respectively. This result was broadly attributed to mechanical interlocking of PLA coating 
with MAO treated alloy as compared to other samples.  
Furthermore, porous calcium silicate (WT) has been considered as a potential bioactive 
material for bone tissue engineering. However, insufficient mechanical strength and high 
degradation rates have limited their biological applications. Wu et al., modify the porous 
calcium silicate with poly D,L-lactic acid (PDLLA) to improve the mechanical properties 
[89]. It was observed that PDLLA-modified WT (WTPL) scaffolds maintained a more 
uniform, continuous inner network, pore size, porosity and interconnectivity of the original 
materials when compared to WT sample alone. As a result of this combination, the 
compressive strength, modulus and percentage strain of the WTPL scaffold were increased 
significantly when compared to WT alone. Moreover, PDLLA modification also improved 
the spreading, adhesion and viability of human bone-derived cells. Hence, it could be 
proposed that the intrinsic properties of PLA can be exploited for potential application for 
bone tissue regeneration. 
6.2.2 Poly (lactic-co-glycolic) acid 
PLGA (Poly(lactic-co-glycolic)acid)) co-polymers are FDA approved for clinical 
applications, mainly due to their excellent biocompatibility [24]. They are hydrolytically and 
enzymatically (trypsin or lysozyme) degraded into glycolic and lactic acid which are easily 
assimilated by metabolic pathways [90]. The physical, mechanical and chemical properties of 
PLGA can be engineered by altering the ratio of the two-co-monomers. Several compositions 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
23 
 
of co-polymer of glycolic acid and lactic acid have been investigated. These co-polymers are 
usually two types (a) (l) LA/GA (b) (dl) LA/GA. The composition of (l) LA/GA ranges of 20 
to 70 % and of 0 to 70% for (dl) LA/GA are amorphous in nature [91]. Reed et al., showed 
that (l) LA/GA co-polymers are more resistant to hydrolysis [92]. The LA/GA (30/70) has the 
higher water absorption capacity and more susceptible to hydrolysis, while the LA/GA 
(50/50) co-polymer is most unstable with respect hydrolysis. These advantages of PLGA 
have been exploited for important applications such as corrosion protection and drug 
delivery.  
Ostrowaski et al., reported on the corrosion and biocompatibility properties of the PLGA 
coating of varying thickness on AZ31and MgY4 alloy for orthopaedic applications [93]. In 
their study, two coatings of different thickness 1.6 μm and 41.8 μm were prepared on AZ31 
alloy, whereas 1.6 μm and 62.1 μm thick coatings were deposited on MgY4 alloy. The 
corrosion resistance was measured using EIS and potential dynamic methods in SBF. It was 
observed that corrosion decreased with increased PLGA thickness. An improvement in 
corrosion resistance was observed for only 3 days, thereafter did not maintain a reduction in 
corrosion rate. The topographical analysis showed that the entrapped gas in the coating 
caused the detachment of coatings from the alloy surface. The biocompatibility studies 
showed enhanced adhesion and proliferation of osteoblast cells. Furthermore, a separate 
study was carried out using pre-treatment of AZ31 alloy and composition of PLGA. The 
alloy was pre-treated to form Mg (OH) 2 layer and subjected to dip coating with PCL and 
PLGA with varying composition (75/25 and 50/50). The corrosion measurements showed 
that PCL offered the greatest resistance, followed by PLGA (50/50) and PLGA (75/25) when 
compared to an uncoated alloy for 1 week in culture medium. Additionally, these coatings 
were biocompatible with good adhesion, proliferation and differentiation of MC3T3E1 
osteoblast cells and human mesenchyme stem cells.  
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Furthermore, Chen et al., exploited the existing regular application of PLGA in drug delivery 
for enhancing the corrosion resistance of Mg alloys [94]. Instead of employing a drug loaded 
PLGA coating, an active PLGA coating was fabricated loaded with inhibitor benzotriazole 
(BTA) through an electrospray process, which is capable of inhibiting corrosion of Mg 
alloys. Principally, it has shown that rapid response of PLGA particle to both water and pH 
change, which lead to instant release of BTA to self-healing the protective functionality, and 
prevent further corrosion.  
Li et al, studied the corrosion and cell adhesion efficacies of PLGA coating on Mg-6Zn alloy 
(Figure 2a and b) [95]. The Mg-6Zn alloy was coated with different concentrations of PLGA 
to enhance the corrosion resistance in 0.9% NaCl solution. The corrosion resistance was 
evaluated by using EIS and potentiodynamic polarisation studies. A significant anticorrosive 
activity was observed with 2% PLGA, but not 4% PLGA. However, both substrates showed 
better corrosion resistance when compared to bare alloy by a factor over 100. The decrease in 
corrosion inhibition with higher concentration of PLGA was attributed to thick coating (76 
μm) and poor adhesion with Mg alloy. Furthermore, PLGA substrate showed good adhesion 
for MC3T3E1 osteoblast cells (Figure 2b). Hence, PLGA co-polymer properties can be 
exploited to prevent the corrosion of Mg based alloys for orthopaedic implants 
6.2.3 Poly caprolactone 
Poly caprolactone (PCL) is the most studied polymer in the family of polylactones [24]. The 
glass transition temperature is -60 ºC and melting point is between 59 ºC to 63 ºC. It degrades 
slower than PLA, and is useful for drug delivery as wells as anti-corrosive coatings. The 
homopolymer PCL has a degradation time about 24 to 36 months. The rate of hydrolysis can 
be altered by co-polymerising with other polymers like valerolactones, dl-lactide etc [24]. For 
example, co-polymers with epsilon caprolactone and dl-lactide have been synthesised to yield 
polymeric material with a higher degradation rate (e.g. biodegradable sutures). PCL is 
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considered to be a nontoxic biodegradable material and suitable as a protective coating on Mg 
based alloy for orthopaedic applications.  
Park et al., studied the varying thickness of PCL for controlled corrosion of Mg for 
orthopaedic applications [96]. Their report studied the layer by layer coating of PCL using 
dip coating with progressive increase in average thickness from 2.8 to 13 μm on pure Mg. 
The degradation rate was measured by evolution of hydrogen gas in Hanks’ solution for 14 
days. It was observed that the rate of degradation decreases with increases in coating 
thickness. However, the high absorption of water was observed in the early stages, damaging 
the coating by decreasing the adhesion of the film on pure Mg. Furthermore, Li et al., 
combined the MAO treatment of pure Mg coatings of PCL polymer to improve its corrosion 
resistance [97]. A uniform PCL coating was prepared on MAO/Mg and corrosion resistance 
measurements were evaluated using potentiodynamic polarisation and immersion test in 
Hanks’ solution for 7 days. Results indicated the significant corrosion resistance of porous 
MAO/Mg/PCL (4-7 %w/v) substrate when compared to an uncoated MAO/Mg sample. Thus, 
pre-treated Mg with PCL coating could be good alternative for orthopaedic. Similarly, 
Degner et al. demonstrated the corrosion resistance of PCL coated pure Mg in DMEM 
(corrosive medium) for one month at 37 ºC through electrochemical investigations [98]. It 
was shown that with increases in the concentration of PCL (2.5 to 7.5 %w/v) the corrosion 
resistance increases 10 folds. Hence, it can be observed that PCL could act as a potential 
protective coating to prevent the corrosion of Mg based alloys for orthopaedic applications 
6.2.4 Polyethylenimine  
Polyethylenimine (PEI) is a polymer that consists of repeating amine group with two carbon 
spacers with melting point of 73-75 ºC [26]. In general, PEI has been applied in polymer 
composite coatings because of its positively charged nature, thereby not only acting as binder 
but also enhancing the corrosion resistance of biodegradable metals. Cai et al., reported the 
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fabrication of anti-corrosive layer-by-layer coating composed of polyethylene imine (PEI), 
polystyrene sulfonate (PSS) and 8-hydroxyquinoline (8HQ) on AZ91D Mg alloys [99]. The 
corrosion resistance of the coating on the alloy was studied by electrochemical measurements 
which showed the corrosion resistance for 4 days in mSBF (modified-SBF). Further, 
biocompatibility of coating was evaluated by studying the alkaline phosphatase activity of 
osteoblast cells, which indicated the higher osteo-differentiation when compared to uncoated 
Mg alloys. Although the number of studies on PEI is limited, but it shows promise as a 
potential protective coating for Mg and its alloys for orthopaedic applications. 
6.3 Natural polymers coatings 
Natural polymers such as collagen, chitosan, stearic acid and serum albumin have been 
studied as coatings on the surface of Mg and its alloys for anti-corrosive as well as 
biocompatible properties [100, 101]. In comparison to sol-gel and synthetic poly-esters, 
natural polymers exhibit excellent biocompatibility due to their biomimetic nature [101]. For 
example, extracellular cell matrix (ECM) components possess cell specific domains such as 
RGD (Arg-gly-Asp) sequence which help in cell attachment [101]. Therefore, natural 
polymer based coatings on implanted material enhance the interactions between the implant 
surface and surrounding tissue matrix, thereby expediting the regeneration of tissues [22]. 
These polymers can also use for surface modifications, hydrogel scaffold synthesis and 
housing drugs for delivery [102]. Currently, the corrosion resistance of biopolymer is poor 
when compared to sol-gel and synthetic-polyester based coatings, and improvement would 
require in depth research work. The list of natural polymers coated on Mg and its alloys to 
study the corrosion resistance is given in Table 5. This section reviews the surface 
modifications of Mg and its alloys by natural polymers coatings to improve the corrosion 
resistance and biocompatibility.  
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6.3.1 Collagen coatings 
Collagen is the major component of extracellular materials of bone matrix. Many reports 
have demonstrated that collagen type-I provides a favourable surface for cell adhesion, 
functions and cell proliferation of bone related-cells [103]. It is expected that a collagen 
coating on Mg and its alloy may be suitable for corrosion resistance, although very few 
reports are available.  
Wang et al, studied the corrosion resistance and biocompatibility of Poly(L-lactic 
acid)/hydroxyapatite/ collagen composite coatings on AZ31 Mg alloys for orthopaedic 
applications [104]. They found that natural polymers like collagen degrades too fast to 
provide any corrosion resistance to Mg, whereas PLLA degrades through an autocatalytic 
effect resulting in a localised excessive acidic environment, where its hydrophobicity 
hampers the cell compatibility. In this disadvantages of composite of Hydroxy apatite 
(HAP)/collagen and PLLA have been offset by considering their respective advantages; 
Firstly, affinity of biomimetic apatite with collagen and their biocompatibility with body fluid 
is favourable; secondly, the porous architecture created by collagen/HAP enhances the 
wettability of PLLA, thereby benefiting the adhesion, cell proliferation and differentiation. It 
was shown that with increasing the mass ratio of PLLA/HA/C (C: collagen) the corrosion 
resistance increased as compared to bare Mg and PLLA coated alloy. Likewise, the overall 
change in pH was controlled with PLLA/HAC when compared to bare Mg AZ91 alloy.  
6.3.2 Chitosan coatings 
Chitosan coating is generally non-toxic and can play an important function as an adhesive 
basal matrix for growing cells during peri-implant healing process and also enhances the 
corrosion resistance of biodegradable metal [105]. Gu et al., studied the surface modification 
of the Mg-1Ca alloy by chitosan to slow down the corrosion in SBF [106]. Different layers of 
chitosan with varied molecular weight were dip coated on the Mg-1Ca alloy. It was shown 
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that coatings produced by 1.5 × 10
5
 and 2.7 × 10
5
 molecular weight chitosan exhibited a 
smooth surface, whereas holes and defects were seen in coatings produced by 1.0 × 10
4
 and 
6.0 × 10
5
 molecular weight equivalents. The alloy with six layers of chitosan (with molecular 
weight 2.7 × 10
5
) was found to be smooth and intact in contrast to surface with one, three or 
nine layers of chitosan coatings. The lower corrosion of Mg-1Ca alloy in terms of change in 
pH and hydrogen evolution gas was observed with six layers produced by 2.7 × 10
5
 
molecular weight chitosan. 
Bai et al., studied the corrosion of MAO/Mg-Zn-Ca Magnesium alloy coated with a 
chitosan/Mg composite in vitro condition [107]. Coatings were prepared by MAO/Mg-Zn-Ca 
alloy followed by dip coating in a chitosan solution. The corrosion study was evaluated by 
anodic polarisation in SBF. It was observed that anticorrosion performance increased 
significantly through composite coatings, however a single layer of chitosan coating provided 
limited corrosion enhancement. The corrosion studies showed nearly 3 fold increase in 
corrosion resistance with composite coatings when compared to bare alloy. Similarly, Liu et 
al., demonstrated the enhanced corrosion resistance of a WE43 Mg alloys, through layer-by-
layer coating of chitosan and polystyrene polymers following MAO treatment [108]. 
Potentiodynamic polarisation and hydrogen evolution measurements showed significant 
improvement in the corrosion resistance of chitosan/polystyrene polymer coated MAO/WE43 
alloy in SBF [108].  
6.3.3 Serum albumin coating 
Serum albumins are the most abundant proteins present in the circulatory system of various 
organisms [109]. They play as a major role in maintaining osmotic blood pressure, drug 
disposition and efficacy [110]. However, the anti-corrosive and biocompatibility properties of 
the serum albumin coating on Mg alloys have not been widely explored. Liu et al., showed 
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that adsorption of bovine serum albumin (BSA) on AZ91 Mg alloy decreases the cathodic 
current and enhance the corrosion resistance in SBF [111]. It was observed that corrosion 
resistance increases with an increase in BSA concentration due to their blocking effect of the 
protein adsorbed layer which can suppresses the dissolution of AZ91 Mg alloys. In another 
study, Killian et al., presented an innovative method to cover the pure Mg with BSA via 
silane coupling chemistry [112]. They used ascorbic acid as a linker and 3-
aminopropyltriethoxy silane (APTES) as a coupling agent for grafting BSA onto a pure Mg 
substrate with Mg samples directly steeped in albumin solution used as controls. It was 
observed that APTES-albumin-Mg sample was smoother with fewer defects than the steeped 
equivalent, as a result in less prone to corrosion. After being treated with SBF for 3 days, the 
surface of the steeped sample exhibited larger pits because of localised corrosion. The 
hydrogen gas evolution decreased from 0.12 ml/cm
2
/day for the polished Mg samples to 
0.075 ml/cm
2
/day after APTES-albumin treated Mg. This indicated that albumin coatings 
attached through silane linker enhanced the alloy corrosion resistance and is a useful method 
for preparing other protein based biocompatible coatings on Mg alloy.  
In general, surface modifications with natural polymers have shown to improve the corrosion 
resistance and biocompatibility properties of Mg and its alloys but literature reports for 
orthopaedic applications are limited. This indicates that the development of these coatings is 
in its infancy. As natural polymers are abundant, other kinds of natural polymers such as 
alginate agar, cellulose, dextran, chitin, casein, chondroitin sulfate etc. offer a wealth of 
coating opportunities.  
6.4 Osteoinductive factor loaded coatings 
In an attempt to overcome the limitations of Mg and its alloy for orthopaedic applications, 
protective coatings loaded with bone growth stimulating factors have been employed. The 
synergistic prevention of corrosion with the release of osteoinductive factors for accelerated 
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healing at the implant site in bone are attractive [113]. However, the concept of drug eluting 
orthopaedic implant is relatively unexplored to date with limited literature. This contracts 
with drug loaded polymer coatings which have been developed extensively in biomedical 
devices such as cardiovascular stents, catheters etc.  
Luo et al., reported the electrochemical deposition of conducting polymer coatings in ionic 
liquids on pure Mg loaded with an anti-inflammatory dexamethasone drug (Figure 3a and b) 
[113]. The authors argued that the ionic liquid is a highly conductive and stable, enabling the 
conductive polymer coatings to be electrodeposited on the Mg under mild conditions. The 
conducting polymer chosen (3,4-ethylenedioxythiophene) (PEDOT) was electrodeposited 
uniformly and improved the corrosion resistance of Mg significantly. The corrosion studies 
claimed a 50% decrease in current density for PEDOT coated Mg over bare Mg. 
Additionally, the PEDOT coating was loaded with dexamethasone during electrodeposition 
and sustained release of the drug was controlled through electrochemical stimulus. Hence, by 
employing conducting polymer coating loaded with a drug, both corrosion resistance and 
biocompatibility were achieved.  
7 Potential challenges in surface modifications on Mg based alloys 
The corrosion mechanism of Mg and its alloying elements still faces several challenges. For 
example, Mg-based alloys containing rare-earth metals are important structural materials, as 
they combine low density with high-strength properties, but have different corrosion 
behaviour. Furthermore, the bio-incompatibility of the alloying elements create an 
unfavourable environment for the bone healing process, which is considered as a big 
challenge in the surface modification on Mg based alloys. Therefore, it is essential to 
investigate the corrosion resistance together with the biocompatible properties of alloying 
elements which might be applied to the development of orthopaedic Mg based implants. 
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In the past decade, polymeric deposit coatings for the corrosion protection and 
biocompatibility are being investigated, and are applied in the commercial applications [114]. 
However, formulations of new and improved polymer which can offer enhanced corrosion 
resistance to Mg and its alloys still faces several challenges. The interface properties of 
polymeric coatings such as adhesion, delamination and the choice of base metal applied for 
studying the efficiency of coatings are the important factors for the quality and stability of 
coatings [115]. However, adhesion test for evaluating the stability and feasibility of polymer 
coatings have rarely been performed in the reported literature. Additionally, important 
parameters like pH, solvents, temperature, electrolytes, kinetics of hydrolysis, pin hole 
formation, crystalline temperature are all of prime importance for the overall understanding 
of the coating / film formation on Mg based alloys. Collectively, the above-mentioned 
concerns could play an important role in large scale industrial production of Mg based 
orthopaedic implants. 
Furthermore, new polymeric material and multiple component systems might be a future of 
the deposit coatings on Mg based alloys. The major advantage of synthetic polyesters (e.g 
PLGA, PCL, PLA) and sol-gel based is the ease of chemical derivatisation [116]. This could 
allow the synthesis of new polymer with desired properties such as enhanced mechanical 
properties, low hydrolysis rate and reduced toxicity. In addition, the blend of two or more 
polymers with desired characteristics or layer-by-layer coating of different polymers can also 
be incorporated in coating systems, in order to achieve stable, anti-corrosive and 
biocompatible deposit coatings for orthopaedic applications.  
8 Conclusions 
Despite of the immense potential of biodegradable Mg alloys for orthopaedic applications, 
the major disadvantage is their high corrosion rate, thereby creating bio-incompatible 
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environment in the surrounding tissues. In order to overcome these drawbacks, strategies 
such as the effect of alloying elements and polymeric surface modifications of Mg and its 
alloys have been discussed. Based on the numerous research carried out, it is concluded that 
alloying elements such as Al, Ca, Mn etc., can react with Mg to form intermetallic phases 
which can dissolve in grain matrix or distribute along the grain boundary, thereby influencing 
the mechanical properties and corrosion behaviour of Mg based alloys. For some elements 
such as Ca and Zn, the corrosion resistance depends upon their concentration in Mg alloys. 
Furthermore, the biocompatibility of these alloying elements on bone related cells is an 
important factor, and the implant should not show cell toxicity. 
Therefore, in depth investigation is required to design the corrosion resistant and 
biocompatible Mg based alloys for orthopaedic applications. Recent research on the effect of 
polymer deposit coatings on corrosion behaviour and biocompatible properties of Mg alloys 
shows that sol-gel and synthetic polyester based coatings have significantly improved the 
corrosion resistant. Numerous studies also highlighted the improvement in corrosion 
properties of natural polymer coatings by incorporating the synthetic polymers. Furthermore, 
sol-gel and synthetic poly-ester coatings have shown the capability as local drug delivery 
platforms, however, there are very limited studies are carried out in the area. Therefore, novel 
strategies need to be designed, which could exploit the multifunctional coatings for the 
development of potential biodegradable orthopaedic Mg based implants. 
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Figures caption 
Figure 1. (I) Potentiodynamic curves of (a) bare magnesium alloy, and super hydrophobic coating on 
magnesium alloy after immersion in 5 wt% NaCl aqueous solution for (b) 30, (c) 60, and (d) 180 min. 
and (II) SEM images of the sample surfaces (a) before and after immersing in 5 wt% NaCl aqueous 
solution for (b) 30, (c) 180, and (d) 1440 mins.( Source: Adapted from Ishikai et al.[77] with 
permission) 
Figure 2.  (I) Potentiodynamic studies of Mg6Zn coated and uncoated with PLGA in 0.9% 
NaCl (II) SEM image of cell morphology on 2% PLGA coated at different time points (a) 1 
day, (b) 2 day, (c) 3 day and (d-f) cell morphology on uncoated Mg6Zn at same time points. 
(Source: Adapted from Li et al [95] with permission). 
Figure 3. (a) Polarisation curves of bare Mg and Mg coated with PEDOT coating in 10 mM 
PBS, pH 7.4 and, (b) Electrical stimulated accumulated drug release of the 
PEDOT/IL/Dex/Mg. (Source: Adapted from Luo et al. [113] with permission). 
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Figure 1: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
52 
 
Figure 2 
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Figure 3: 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
54 
 
Table 1: Selected surgical metal implants/ material physical properties 
 
 
 
Tissue/Surgical Implants 
Density 
(g/cm
3
) 
Yield 
strength 
(MPa) 
Tensile 
strength 
(MPa) 
Elongation 
to break 
(%) 
Elastic 
Modulus 
(GPa) 
Ref 
Bone 1.8-2.1 104-121 110-130 0.7-3 15-25 
[117] 
Biodegradable metal alloys 
 
 
Mg and its 
alloys 
Pure Mg 1.74-2.0 65-100 90-190 2-10 41-45 [1 ] 
AZ31  1.78 185 263 15-23 45 [118], 
[119] 
AZ91 1.81 160 150 2.511 45 
WE43 1.84 170 220 2-17 44.2 [120] 
Fe and Mn 
alloys 
Fe20Mn 7.73 420 700 8 207 [121] 
Fe35Mn ---- 230 430 32 --- 
Zn based 
alloys 
Zn–Al–Cu 5.79 171 210 1 90 
[122] 
Non-degradable 
metal/composite implants  
 
Stainless 
Steel 
SS316L 7.9 190 490 40  200 
[123] 
Titanium 
alloys 
Ti-6Al-4V 4.43 880 950 14 113.8  
[124] 
Ti-6Al-7Nb 4.52 800 900 10 105 
Chromium-
cobalt alloys 
CoCr20Ni15Mo7 
  
7.8 
  
240-450 450 -960 50 195 - 230 
[125] 
Bioceramics 
Alumina 
Ceramics 
4 
  
--- 400-580 0.12 260 – 410 
[126] 
Synthetic 
hydroxyapetite 
3.15 
  
--- 
40 – 200 
  
---- 
70 – 120 
  
Natural and synthetic 
polyesters  
 
Natural and 
synthetic  
polyesters 
Collagen (Rat 
tail) 
--- ---- 2.6-605 7.40-26.74 
5 – 11.5 
  
[127] 
PLGA 1.30-1.34 3.8-26.6 13.9-16.7 5.7 1.69 [128] 
PCL 1.145 8.37-14.66 68.45-102.7 22.8-28.3 281-686 [129] 
PLA (67Kda) 
PLA-59Kda 
PLA-31Kda 
1.8 
1.64 
1.04 
70 
68 
65 
59 
58 
55 
7.0 
5.0 
5.5 
3750 
3750 
3550 
[130] 
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Table 2: Corrosion studies of Mg and its alloys 
Mg 
base
d 
Meta
ls 
  
       In vitro degradation 
 
Ref 
     In vivo corrosion 
 
 
Ref
. 
  
Durat
ion 
(days
) 
Degrad
ation 
rate 
(mm/yr
) 
Unless 
specifie
d 
 
Corro
sive  
Mediu
m 
Method/ 
Test 
 
Durat
ion of 
impla
nt 
(days
) 
Degrad
ation 
rate 
(mm/yr
) 
Unless 
specifie
d 
Method 
/Test 
 
Implant 
site 
 
Ani
mal 
 
 
 
 
 
 
 
Pure 
Mg 
 
   7 
0.572 EBSS  
 
 
 
Weight  
loss 
 
 
 
 
 
[13
1] 
14 0.39 Reductio
n in  
Volume 
 
Ulnae 
 
 
Rab
bit 
 
[13
2] 
 
0.728 MEM 21 0.21 
2.185 MEM
p 
56 30-40%  
 
 
   14 
0.468 EBSS 30 1.0 ± 
0.3 
 Weight 
loss 
muscle 
fascia 
 
 
Rat 
 
 
[13
3] 
 
0.676 MEM 60 0.7±0.3 
1.483 MEM
p 
 
 
- 
 
 
 
 
 
 
- 
 
 
- 
 
 
 
 
 
 
- 
 
 
- 
 
 
 
 
 
 
- 
 
 
 
- 
 
 
 
 
 
- 
 
 
- 
 
 
 
 
 
 
- 
 
 
- 
 
 
 
 
 
 
- 
 
 
  21 
0.382 EBSS 
0.659 MEM 
1.37 MEM
p 
 
4 
8 
20 
Estimat
ed 
4.5 
2.5 
2.2 
 
 
 SBF 
 
 
Weight 
loss 
 
 
[13
4] 
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3 9.1 
mg/cm
2 
 
HBSS 
 
 
Weight 
loss 
 
[13
5] 7 0.094 
mg/cm
2 
14 0.88 Nor’s 
soluti
on 
Weight 
loss 
 
[13
6] 
6 0.57 
 
AZ3
1 
 
3 
 
7 
 
15 
 
20 
 
25 
Estimat
ed 
4 
mg/cm
2 
 
5 
mg/cm
2 
 
12 
mg/cm
2 
 
16 
mg/cm
2 
 
22 
mg/cm
2 
 
 
SBF 
 
 
Weight 
loss 
 
 
 
[13
7] 
 
7 
 
 
 
 
0.335 
 
 
Weight 
loss 
 
 
 
Subcutan
eous 
 
 
Rat 
 
 
[13
1] 
 
14 
 
0.335 
 
21 
 
0.223 
 
42 
 
1.2 
mm
2 
 
Weight 
loss 
 
Femora 
 
Guni
ea 
pig 
 
[27
] 
 
 
7 
 
 
0.795 
 
EBSS 
 
Weight 
loss 
 
 
[13
1] 
 
126 
 
1.6 
mm
2
  
1.291 
 
MEM 
 
1.937 
 
MEM
p 
 
 
14 
 
0.670 
 
EBSS 
 
Weight 
loss 
 
 
- 
 
 
 
 
 
- 
 
- 
 
 
 
 
 
- 
 
- 
 
 
 
 
 
- 
 
- 
 
 
 
 
 
- 
 
- 
 
 
 
 
 
- 
 
- 
 
 
 
 
 
- 
 
- 
 
 
 
 
 
 
 
1.018 
 
MEM 
 
1.291 
 
MEM
p 
 
 
21 
 
0.546 
 
EBSS 
 
Weight 
loss 
 
 
1.192 
 
MEM 
 
0.944 
 
MEM
p 
 
 
 
 
AZ9
1 
 
1 
    
    -- 
 
 
 
Nor’s 
soluti
on 
 
 
 
 
Weight 
loss 
 
 
 
 
[13
3] 
 
126 
 
 
1.3 
 
SμCT 
 
Femora 
 
Guin
ea 
pig 
 
 
 
[3] 
 2 6.7 42 0.43 Area 
reductio
n 
3 
 
8.5  
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4 3.5 
 
 
- 
 
 
 
- 
- - - 
7 6 SBF2
7 
Weight 
loss 
[13
6] 
 
AZ9
1D 
10 
days 
-0.267 Ocean 
water 
Substi
tute 
Immersion 
 
[13
8] 
 14 1.17 Weight 
loss 
Subcutis  
Nud
e 
mice 
[13
9] 
5.72  
1 M 
NaCl 
 
Electroche
mical 
 
 
[14
0] 
126  
0.00035
16 
Vol. 
reductio
n 
Femur Guni
ea 
pig 
[13
8] 
0.66  
 
 
- 
 
 
 
- 
 
 
 
- 
 
 
 
- 
 
 
 
- 
 
2.93 
 
5 
7 
15 
20 
25 
Estimat
ed  
4 
mg/cm
2 
5 
mg/cm
2 
6 
mg/cm
2 
5 
mg/cm
2 
4.2 
mg/cm
2 
 
 
SBF 
 
 
 
Weight 
loss 
 
 
[13
7] 
 
 
 
LAE
442 
 
10 
6.9 Ocean 
water 
Substi
tute 
Electroche
mical 
[13
8] 
14 0.0134 μCT Medullar
y cavity 
Rab
bit 
[14
1] 
5.535 Weight 
loss 
[14
2] 
126 1.205 
x10
-4 
SμCT Femora Guin
ea 
pig 
[13
8] 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
 
 
- 
365 40% %vol. 
reductio
n 
Tibia  Rab
bit 
[14
3] 
 
42 1.6 
mm
2
 
 
Weight 
loss 
 
 
Femora 
 
Guin
ea 
pig 
 
 
[27
] 
 126 1.45 
mm
2
 
60 0.02 
cm
3
 
(decrea
sed) 
 
Volume  
determin
ation 
 
  
Tibiae 
 
Rab
bit 
 
[14
4] 
120 0.03 
cm
3 
decreas
ed 
 
 
Mg-
0.8C
a 
 
7 
 
0.573  
EBSS 
 
 
Weight 
loss 
 
 
[13
1] 
      
0.937  
MEM 
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2.812  
MEM
p 
      
14 0.521  
EBSS 
        
 0.833 MEM  
Weight 
loss 
 
[13
1] 
365 
 
62% 
 
% vol. of  
Reductio
n 
 
Tibia 
 
Rab
bit 
 
[14
3] 
1.901  
MEM
p 
7 0.312  
 
Weight 
loss 
 
 
 
Subcutan
eous 
 
 
 
Rat 
 
 
[13
1] 
21 0.382  
EBSS 
 
 
Weight 
loss 
14 0.430 
0.764  
MEM 
21 0.351 
1.545  
MEM
p 
60 
 
0.02 
cm
3
 
(Decrea
sed) 
 
0.05 
cm
3 
(Decrea
sed) 
 
 
Volume  
determin
ation 
 
Tibiae 
 
Rab
bit 
 
[14
4] 
 
 
120 
 
 
 
 
 
 
 
WE4
3 
0 0.79 0.01 
M 
NaCl 
 
Electroch-
emical 
 
[14
5] 
42 1.2 
mm
2 
 
Weight 
loss 
 
Femora 
 
 
 
Guin
ea 
pig 
 
 
[27
] 
  
- 
2.91 0.2 M 
NaCl 
126 1.0 
mm
2 
 
- 
4.10 0.6 M 
NaCl 
60 
 
0.01 
cm
3
 
(Decrea
sed) 
 
 
Volume  
determin
ation 
 
Tibiae 
 
Rab
bit 
 
[14
4] 
- 5.84 1.0 M 
NaCl 
120 
 
0.06 
cm
3 
(Decrea
sed) 
 
- 6.97 2.0 M 
NaCl 
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Table 3: Elemental compositions (%wt.) of selected Mg alloys             
 
 
Magnesium 
alloys 
Ca Al Mn Zn Li Nd Zr Y Mg 
Other trace 
elements (% 
wt.) 
 
Ref. 
AZ31 - 2.4 0.4 0.8 - - - - 96.7 
Cu-0.008,Fe-
0.003, Be-0.005 
[27] 
[33] 
[146] 
AZ91 - 9.0 0.13 0.5 - - - - 90.37 
Cu-0.003,Fe-
0.014, Be-0.002 
WE43 - - - - - 2.4-3.2 0.4 3.7-4.3 92.1-93.5 - 
[146] 
LAE442 - 2.2 0.2 0.2 3.9 2.0 - - 91.5 - 
[27] 
AM60 - 6.0 0.13 0.1 - - - 
- 
 
93.77 
Cu-0.008,Fe-
0.004, Be-0.005 
[146] 
MgCa0.8 0.8 - - - - - - - 99.2 - 
[146] 
Mg6Zn 6 - - - - - - - 94 - 
[146] 
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                 Table 4: Pathophysiology of alloying elements in Mg alloy (Ref: [15], [139], [140], [54], [55]). 
Elements 
 
Effect on the alloying 
element 
Normal 
amount 
present in 
human 
body 
Pathophysiology Toxicology 
TD50 of 
Bone related cells 
(mol/L) 
 
Mg 
  
------ 
25 g 
Normal blood serum level 0.73-
1.06 mmol/L 
Required for ATP synthesis. 
activator of many enzymes; co-
regulator of protein synthesis, 
stabiliser of DNA and RNA 
Disorder in magnesium 
homeostasis leads to 
nausea, renal failure, 
impaired breathing. 
 
73× 10
−3
 
Ca 
Induce Corrosion 
resistance in Mg-Ca 
alloys 
1100 g 
Normal serum level 0.919-0.993 
mg/L 
Control muscle contraction, 
maintain homeostasis of bone, 
hormones and neurotransmitter 
release regulator 
Dysregulation of calcium 
levels in the body leads 
to kidney stones, 
Hypoparathyrodism, 
cardiac unrest 
>50× 10
−3
 
Al 
 Acts as passivating 
element and improve 
corrosion resistance 
<300 mg Normal blood serum level 2.1-4.8 
µg/L. 
Excess amounts leads to 
neurotoxicity, 
Alzheimer's, 
accumulation in bone 
leads to decreases 
osteoclast viability. 
>5× 10
−3
 
Zn 
Improves compatibility 
with bone by modifying 
yield stress and Elastic 
modulus. 
Decreases H
2
 gas 
release 
2 g 
Normal blood serum level 12.4-
17.4 µmol/L 
Essential elements for immune 
system. 
Excessive amounts leads 
neurotoxic, cramps and 
diarrhoea 
9.28 × 10
−5
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Mn 
Improve corrosion 
resistance 
12 mg 
Normal blood serum level < 0.8 
µg/L 
Activator of various enzymes 
Excessive amounts cause 
psychiatric and motor 
disturbances 
4.59 × 10
−5
 
Li 
Improve corrosion 
resistance 
-- 
Normal blood serum level 2-4 
ng/g 
Used in the treatment of 
depressive disorders 
Overdose causes 
impaired kidney function 
and respiratory disorders 
1.32 × 10
−2
 
Cu 
Increase strength of 
Magnesium cast 
-- 
normal blood serum level 74-131 
µmol/L 
Involved in respiratory chain and 
enzyme co-factors 
Causes hypotension, 
jaundice, melena etc. 
4.15 × 10
−5
 
Y 
Improve ductility and 
corrosion resistance 
  
-- 
Blood serum level < 47µg 
  
Higher concentration 
accumulate in liver and 
gall bladder 
2.54 × 10
−4
 
Zr 
Improve tensile 
strength, ductility and 
corrosion resitance 
<250 mg Low systemic toxicity 
Deposited on bone and 
cationic form cause 
deposition on bone 
1.64 × 10
−3
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Table 5: Corrosion studies of polymers coated on Magnesium alloy 
 
Polymer
s/ 
Composi
tes 
Degraded products 
Magnesium alloy 
substrate 
 
 
 
Icorr 
(μA/cm
2 
,unless
 
Indicat
ed) 
 
 
 
 
Ecor
r 
(V) 
 
 
 
 
Corrosi
on 
Mediu
m 
 
 
 
 
Coating 
Method 
 
 
 
 
Ref. 
  
Syntheti
c 
polyeste
rs 
Poly 
Lactic 
acid 
Lactic acid 
PLA-AZ31 
7.72
 
-
1.5
7 
 
 
SBF 
 
 
 
 
 
Dip 
coating 
 
[85] 
 
 
PLA-MAO-AZ31 
1.83
 
-
1.5
0 
 
Mg-1.21Li-
1.12Ca-1.0Y 
1.7 -- 
 
Hanks’  
buffer 
[147
] 
 
PLGA 
d.l-lactic acid 
and glycolic acid 
Mg Ammlite 3 -
1.5
2 
 
0.1 M 
NaCl 
Electrospra
y 
[94] 
Mg-6Zn 0.085
 
-
1.4
4 
0.9% 
NaCl 
Dip 
coating 
[95] 
AZ31-PLGA 10 % 5.20 -
1.4
69 
 
 
DMEM 
 
 
 
 
 
Dip 
coating 
 
 
 
[93] 
 AZ31-PLGA 20 % 6.05
 
-
1.4
5 
Mg4Y-PLGA 10 % 8.09 -
1.4
85 
Mg4Y-PLGA 20 % 6.85
 
-
1.4
69 
PLGA 50:50 1.12 -
1.5
2 
 
DMEM 
 
 
Dip 
coating 
 
 
[148
] 
 PLGA 75:25 1.56 -
1.4
4 
Poly(cap
ro-
Caproic acid MAO–4PCL duplex 
coated 
0.81 −1.
72 
Hanks’ 
buffer 
 
 
[97] 
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lactone)   Dip 
coating 
 
 
 Mg MAO–7PCL 
duplex coated Mg 
0.0045
 
 
−1.
53 
 
Mg- PCL 2.5 wt% 7 --  
 
DMEM 
Spin 
coating 
 
[98] 
 
Mg- PCL 5 wt% 0.1 -- 
Mg- PCL 7.5 wt% 0.02 -- 
PCL-AZ91-LPM  
Reduce
d 
1.4
4 
 
SBF 
Spray 
coating 
129 
PCL-AZ91-HPM 1.1
4 
Linear 
Poly-
ethylene 
imine) 
Ethylene glycol and 
amine 
AZ91D-
PEI/PSS/8HQ/PSS 
 
24.82 
 
-
1.7
32 
 
m-SBF 
 
Spin 
coating 
 
[99] 
Sol-gel 
coatings 
 
DEPETE
S& 
BTESPT 
- 
Mg-6Zn-Ca -1(M) 
M-
DEPETES:1BTESP
T 
1.20× 
10
−2
 
-
1.3
9 
 
 
 
 
 
m-SBF 
 
 
 
 
Dip 
coating 
 
 
 
[73] 
 
M-
DEPETES:2BTESP
T 
 
 
7.24x10
−3 
 
 
-
1.3
5 
 
 
M-
1DEPETES:3BTES
PT 
 
 
2.45 
x10
−3 
 
-
1.3
7 
 
 
M-
1DEPETES:4BTES
PT 
 
7.59 
x10
−4
 
-
1.3
8 
 
TiO2 - 
Mg-MAO-TiO2 12.5 -
1.9
3 
Hanks’ 
solution 
Dip 
coating 
[75] 
Natural 
Polymer
s 
 
Chitosan 
Glucosamine and keto-
olligosacchraide 
Chi/MAO/Mg–
Zn–Ca-120V 
 
 
 
14 
 
-
1.54
9 
 
Na2PO4
+ 
NaOH 
 
 
 
Na2PO4
+ 
Dip 
coating 
 
[107
] 
 
 
  Chi/MAO/Mg–
Zn–Ca-140V 
0.59 
 
-
1.49
9 
Dip 
coating 
130] 
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NaOH 
MAO-WE43-
chitosan-
polystyrene-
LBL 
 
2.796 -
1.29
5 
 
 
SBF 
Spin 
coating 
 
[101
] 
AZ91E-5% 
chitosan 
0.322 -
1.56
2 
- 
 
Synthet
ic 
Sweat 
 
Dip 
coating 
[100
] 
AZ91E-10% 
chitosan 
0.136 -
1.53
5 
 
AZ91E-15% 
chitosan 
0.116 1.48
3 
 
Natural 
polymer 
Composi
tes 
 
 
HA-
chitosan 
CaPO4 and 
Glucosamine and keto-
olligosacchraide 
HA-5 wt.% 
chitosan-AZ31 
15.1 -
1.60
1 
 
 
SBF 
 
 
Spray 
coating 
 
[13
1] 
HA-10 wt.% 
chitosan- 
AZ31 
31.4 -
1.58
1 
 
HA-20 wt.% 
chitosan-AZ31 
50.9 -
1.58
6 
Stearic 
acid 
and 
magnesi
um state 
Stearic acid 
 
AZ31 
 
4 
 
 
-1.71 
 
Hanks’ 
solutio
n 
 
 
Dip coating 
 
[14
9] 
Collagen 
Hydroxylysine/proline/hydro
xyproline 
AZ31 
0.00223 -1.48 SBF Electrospin
ning 
 
[15
0] 3.741 -
1.46
0 
    SBF  Dip coating 
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Highlights: 
 The Mg based alloys are promising candidates for orthopaedic applications. 
 The rapid corrosion of Mg can affect human cells, causes infection and implant 
failure. 
 The various physiological factors and Mg alloying elements affecting the corrosion 
and mechanical properties of implants. 
 The polymeric deposit coatings enhance the corrosion resistance and biocompatibility. 
